ICON Clinical Research Belgium SRL

331.4 FTE

ICON Clinical Research Belgium reported revenue of €42.5m for the 2024 financial year (annual accounts filed with the NBB on 10 Dec 2025), with 331.4 full-time equivalents.

By total assets for 2024, ICON Clinical Research Belgium ranks among the 1,000 largest of the 47,112 companies in its sector (NACE 7020) in Belgium that filed accounts for that financial year. Largest companies in the sector →

Company number (CBE) 0467.032.927 · VAT BE0467032927
2800 Mechelen
active in Business and other management consultancy activities (NACE 70200)
operating since 08 Oct 1999 (≈ 27 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of ICON Clinical Research Belgium shows with a free account.

See the score
Profile
SRL Large · 331.4 FTE since 1999
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2024

Revenue€42.5m
Net result€2.88m
Equity€13.6m
Cash823,007 €
EBITDA€4.65m
Total assets€20.6m
Headcount (avg FTE)331.4
The line marks its sector median: 58.4% (26338 companies).

Change 2021 → 2024: Revenue +115 % Equity +124 % Total assets +121 % Headcount (avg FTE) +66 %

Accounts of the company itself (not consolidated).

The full file covers 9 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

ICON Clinical Research Belgium's annual accounts

20242023202220212020
Revenue€42.5m
Net result€2.88m
Equity€13.6m
Cash823,007 €
EBITDA€4.65m
Total assets€20.6m

Filed annual accounts

  • Year ended 31 Dec 2024filed on 10 Dec 2025
  • Year ended 31 Dec 2023filed on 20 Dec 2024
  • Year ended 31 Dec 2022filed on 12 Jul 2024
  • Year ended 31 Dec 2021filed on 08 Sep 2023
  • Year ended 31 Dec 2020filed on 02 Nov 2021

ICON Clinical Research Belgium's financial analysis

Management and control of ICON Clinical Research Belgium

3 active director(s) in the register.

ICON Clinical Research Belgium's shareholders and holdings →

ICON Clinical Research Belgium's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0467.032.927
VAT number
BE0467032927
Peppol
Registered · 0208:0467032927 · as of 14 Nov 2026
Legal form
SRL
Incorporated
08 Oct 1999
Registered office
2800 Mechelen
Size
Large · 331.4 FTE
Latest accounts
2024 · filed on 10 Dec 2025
Activity
Business and other management consultancy activities (NACE 70200)

ICON Clinical Research Belgium (SRL) has been based in Mechelen since 1999, active in: business and other management consultancy activities. For 2024, it reports revenue of €42.5m, a net profit of €2.88m and equity of €13.6m. With 331.4 full-time equivalents, it is a large enterprise by headcount. Its solvency stands at 66.2%, above the median of its sector (58.4%).

Guide: Checking a Belgian supplier invoice: numbers and IBAN →

Companies similar to ICON Clinical Research Belgium

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about ICON Clinical Research Belgium

What is the revenue of ICON Clinical Research Belgium?

According to the 2024 annual accounts filed with the NBB, the revenue of ICON Clinical Research Belgium amounts to 42,524,003 €.

What is the VAT number of ICON Clinical Research Belgium?

In Belgium, the VAT number is the company number prefixed with BE: BE0467032927 for ICON Clinical Research Belgium, if the company is VAT-registered. Its company number (CBE) is 0467.032.927.

Where is the registered office of ICON Clinical Research Belgium?

According to the CBE register, the registered office of ICON Clinical Research Belgium is in 2800 Mechelen.

What is the equity of ICON Clinical Research Belgium?

At the close of the 2024 financial year, the equity of ICON Clinical Research Belgium amounts to 13,625,902 €, a solvency of 66.2% of total assets.

How many people work at ICON Clinical Research Belgium?

331.4 full-time equivalents on average according to the 2024 social balance sheet.

Who manages ICON Clinical Research Belgium?

The register lists 3 active mandates at ICON Clinical Research Belgium. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

How large is ICON Clinical Research Belgium within its sector?

By total assets for 2024, ICON Clinical Research Belgium ranks among the 1,000 largest of the 47,112 companies in its sector (NACE 7020) in Belgium that filed accounts for that financial year.

Idonis

The full file of ICON Clinical Research Belgium

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 10 Jul 2026

No credit card, no commitment.

What each plan unlocks →